Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)

CUSIP: 05156V102

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Shares, no par value
Shares outstanding
132,929,348
Total 13F shares
62,001,205
Share change
+4,366,942
Total reported value
$498,579,335
Put/Call ratio
70%
Price per share
$8.04
Number of holders
210
Value change
+$33,892,897
Number of buys
99
Number of sells
78

Quarterly Holders Quick Answers

What is CUSIP 05156V102?
CUSIP 05156V102 identifies AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q1 2025

As of 31 Mar 2025, Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by 210 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 62,001,205 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, BlackRock, Inc., ARMISTICE CAPITAL, LLC, NEA Management Company, LLC, STATE STREET CORP, MORGAN STANLEY, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, and GOLDMAN SACHS GROUP INC. This page lists 211 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.